Recent Posts

1. 

   FOR SALE

   Oh, Karen. You’re dumb.

   Esperion

   anonymous

   May 15, 2024 at 8:00 PM

2. 

   Is JNJ a good place to work for Gay’s?

   They actually hired a real drag queen to come out as a celebration for pride month last year in irvine. It was a lot of fun.

   Johnson & Johnson

   anonymous

   May 15, 2024 at 7:50 PM

3. 

   Amgen revisiting Akebia buyout

   why doesn’t CSL Vifor acquire them and cut Amgen as the middle man. That way all of profit stays with Vifor. Is there an antitrust law if Vifor owns the HIF drug sold to Fresenius? I don’t think so

   Amgen

   anonymous

   May 15, 2024 at 7:36 PM

4. 

   Promotion?

   #hoelogic

   Hologic

   anonymous

   May 15, 2024 at 7:31 PM

5. 

   All CrossLink read this!

   Awareness and training will provide understanding on why it is not worth risking the lucrative implant revenue or the relationships that have been built for many years. This is just a way for Heron to get in with Ortho where they couldn’t on...

   Heron Therapeutics

   anonymous

   May 15, 2024 at 7:27 PM

6. 

   Phathom

   Really motivated after that Q1 bonus. Motivated to find a new job.

   Biotech Startups

   anonymous

   May 15, 2024 at 7:27 PM

7. 

   Sotyktu floundering

   Karen, for the love of Christ, we are on page 82 of this thread, can you please specify why leadership from Novartis is too blame and not the drug itself...i repeat we are on page 82 and still no details.. just more blanket Karen statements...

   Bristol-Myers Squibb

   anonymous

   May 15, 2024 at 7:26 PM

8. + Show More